Sirtuins: NAD+-dependent deacetylase mechanism and regulation

Current Opinion in Chemical Biology

Volumn 16, Issue 5-6, 2012, Pages 535-543

  Sauve, Anthony A ^a   Youn, Dou Yeon ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' O ACETYL ADENOSINE DIPHOSPHATE RIBOSE; ACETYL COENZYME A; ADENOSINE DIPHOSPHATE RIBOSE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT DEACETYLASE; PYRUVIC ACID; SIRTUIN; SUCCINYL COENZYME A; UNCLASSIFIED DRUG;

CATALYSIS; CHEMICAL STRUCTURE; CITRIC ACID CYCLE; DEACETYLATION; ENZYME ACTIVE SITE; GLYCOLYSIS; OXIDATIVE PHOSPHORYLATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW;

ACETYLATION; ANIMALS; HUMANS; IMIDOESTERS; MODELS, MOLECULAR; NAD; NIACINAMIDE; SIRTUINS;

EID: 84872268055     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2012.10.003     Document Type: Review

References (59)

1. Sauve A.A., Wolberger C., Schramm V.L., Boeke J.D. The biochemistry of sirtuins. Annu Rev Biochem 2006, 75:435-465.
2. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
3. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006, 23:607-618.
4. Smith J.S., Brachmann C.B., Celic I., Kenna M.A., Muhammad S., Starai V.J., Avalos J.L., Escalante-Semerena J.C., Grubmeyer C., Wolberger C., et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci USA 2000, 97:6658-6663.
5. Brachmann C.B., Sherman J.M., Devine S.E., Cameron E.E., Pillus L., Boeke J.D. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev 1995, 9:2888-2902.
6. Miller E.S., Heidelberg J.F., Eisen J.A., Nelson W.C., Durkin A.S., Ciecko A., Feldblyum T.V., White O., Paulsen I.T., Nierman W.C., et al. Complete genome sequence of the broad-host-range vibriophage KVP40: comparative genomics of a T4-related bacteriophage. J Bacteriol 2003, 185:5220-5233.
7. Vaquero A., Reinberg D. Calorie restriction and the exercise of chromatin. Genes Dev 2009, 23:1849-1869.
8. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012, 13:225-238.
9. Burnett C., Valentini S., Cabreiro F., Goss M., Somogyvari M., Piper M.D., Hoddinott M., Sutphin G.L., Leko V., McElwee J.J., et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011, 477:482-485.
10. Guarente L. Franklin H. Epstein Lecture: sirtuins, aging, and medicine. N Engl J Med 2011, 364:2235-2244.
11. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
12. Landry J., Slama J.T., Sternglanz R. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun 2000, 278:685-690.
13. Sauve A.A., Celic I., Avalos J., Deng H., Boeke J.D., Schramm V.L. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions. Biochemistry 2001, 40:15456-15463.
14. Tanner K.G., Landry J., Sternglanz R., Denu J.M. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 2000, 97:14178-14182.
15. Jackson M.D., Denu J.M. Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta-NAD+-dependent histone/protein deacetylases. J Biol Chem 2002, 277:18535-18544.
16. Min J., Landry J., Sternglanz R., Xu R.M. Crystal structure of a SIR2 homolog-NAD complex. Cell 2001, 105:269-279.
17. Paulsen H., Behre H. Carboxonium compounds in carbohydrate chemistry. 7. Valence isomerism in acyloxonium cations of 1,2,3-triols. Simple synthesis of acyloxonium salts. Angew Chem Int Ed 1969, 8. 886.
18. Wu Z., Stanley R.R., Pittman C.U. Selective diesterification of diols through cyclic ketene acetal intermediates. J Org Chem 1999, 64:8386-8395.
19. Giner J.L., Li X., Mullins J.J. Mechanistic studies of the biomimetic epoxy ester-orthoester and orthoester-cyclic ether rearrangements. J Org Chem 2003, 68:10079-10086.
20. Smith B.C., Denu J.M. Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine. Biochemistry 2006, 45:272-282.
21. Sauve A.A., Schramm V.L. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 2003, 42:9249-9256.
22. Jackson M.D., Schmidt M.T., Oppenheimer N.J., Denu J.M. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J Biol Chem 2003, 278:50985-50998.
23. Hawse W.F., Hoff K.G., Fatkins D.G., Daines A., Zubkova O.V., Schramm V.L., Zheng W., Wolberger C. Structural insights into intermediate steps in the Sir2 deacetylation reaction. Structure 2008, 16:1368-1377.
24. Bruice T.C. A view at the millennium: the efficiency of enzymatic catalysis. Acc Chem Res 2002, 35:139-148.
25. Sauve A.A. Sirtuin chemical mechanisms. Biochim Biophys Acta 2010, 1804:1591-1603.
26. Smith B.C., Denu J.M. Sir2 deacetylases exhibit nucleophilic participation of acetyl-lysine in NAD+ cleavage. J Am Chem Soc 2007, 129:5802-5803.
27. Sanders B.D., Jackson B., Marmorstein R. Structural basis for sirtuin function: what we know and what we don't. Biochim Biophys Acta 2010, 1804:1604-1616.
28. French J.B., Cen Y., Sauve A.A. Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase. Biochemistry 2008, 47:10227-10239.
29. Egea P.F., Muller-Steffner H., Kuhn I., Cakir-Kiefer C., Oppenheimer N.J., Stroud R.M., Kellenberger E., Schuber F. Insights into the mechanism of bovine CD38/NAD+glycohydrolase from the X-ray structures of its michaelis complex and covalently-trapped intermediates. PLoS ONE 2012, 7:e34918.
30. McCann J.A., Berti P.J. Transition-state analysis of the DNA repair enzyme MutY. J Am Chem Soc 2008, 130:5789-5797.
31. Schramm V.L. Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes. Annu Rev Biochem 2011, 80:703-732.
32. Hu P., Wang S., Zhang Y. Highly dissociative and concerted mechanism for the nicotinamide cleavage reaction in Sir2Tm enzyme suggested by ab initio QM/MM molecular dynamics simulations. J Am Chem Soc 2008, 130:16721-16728.
33. Cen Y., Sauve A.A. Transition state of ADP-ribosylation of acetyllysine catalyzed by Archaeoglobus fulgidus Sir2 determined by kinetic isotope effects and computational approaches. J Am Chem Soc 2010, 132:12286-12298.
34. Zhou G.C., Parikh S.L., Tyler P.C., Evans G.B., Furneaux R.H., Zubkova O.V., Benjes P.A., Schramm V.L. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states. J Am Chem Soc 2004, 126:5690-5698.
35. Williams A. Dilute acid-catalyzed amide hydrolysis - efficiency of N-protonation mechanism. J Am Chem Soc 1976, 98:5645-5651.
36. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., Zhao W., Thiyagarajan M., MacGrogan D., Rodgers J.T., et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006, 281:21745-21754.
37. Sauve A.A., Moir R.D., Schramm V.L., Willis I.M. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol Cell 2005, 17:595-601.
38. McClure J.M., Wierman M.B., Maqani N., Smith J.S. Isonicotinamide enhances Sir2 protein-mediated silencing and longevity in yeast by raising intracellular NAD+ concentration. J Biol Chem 2012, 287:20957-20966.
39. Anderson R.M., Bitterman K.J., Wood J.G., Medvedik O., Sinclair D.A. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 2003, 423:181-185.
40. Bitterman K.J., Anderson R.M., Cohen H.Y., Latorre-Esteves M., Sinclair D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 2002, 277:45099-45107.
41. Vocadlo D.J., Davies G.J. Mechanistic insights into glycosidase chemistry. Curr Opin Chem Biol 2008, 12:539-555.
42. He Y., Macauley M.S., Stubbs K.A., Vocadlo D.J., Davies G.J. Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J Am Chem Soc 2010, 132:1807-1809.
43. Zhu X., Schmidt R.R. New principles for glycoside-bond formation. Angew Chem Int Ed Engl 2009, 48:1900-1934.
44. Fatkins D.G., Monnot A.D., Zheng W.P. N-epsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine N-epsilon-deacetylation. Bioorg Med Chem Lett 2006, 16:3651-3656.
45. Jin L., Wei W., Jiang Y., Peng H., Cai J., Mao C., Dai H., Choy W., Bemis J.E., Jirousek M.R., et al. Crystal structures of human SIRT3 displaying substrate-induced conformational changes. J Biol Chem 2009, 284:24394-24405.
46. Smith B.C., Denu J.M. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide. Biochemistry 2007, 46:14478-14486.
47. Fatkins D.G., Zheng W. Substituting N(epsilon)-thioacetyl-lysine for N(epsilon)-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD(+)-dependent protein deacetylases. Int J Mol Sci 2008, 9:1-11.
48. Huhtiniemi T., Suuronen T., Lahtela-Kakkonen M., Bruijn T., Jaaskelainen S., Poso A., Salminen A., Leppanen J., Jarho E. N(epsilon)-modified lysine containing inhibitors for SIRT1 and SIRT2. Bioorg Med Chem 2010, 18:5616-5625.
49. Kiviranta P.H., Suuronen T., Wallen E.A., Leppanen J., Tervonen J., Kyrylenko S., Salminen A., Poso A., Jarho E.M. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors. J Med Chem 2009, 52:2153-2156.
50. Suzuki T., Asaba T., Imai E., Tsumoto H., Nakagawa H., Miyata N. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine. Bioorg Med Chem Lett 2009, 19:5670-5672.
51. Hirsch B.M., Gallo C.A., Du Z.W., Wang Z.H., Zheng W.P. Discovery of potent, proteolytically stable, and cell permeable human sirtuin peptidomimetic inhibitors containing N-epsilon-thioacetyl-lysine. Medchemcomm 2010, 1:233-238.
52. Cen Y., Falco J.N., Xu P., Youn D.Y., Sauve A.A. Mechanism-based affinity capture of sirtuins. Org Biomol Chem 2010, 9:987-993.
53. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics 2007, 6:812-819.
54. Lin H., Su X., He B. Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem Biol 2012, 7:947-960.
55. Zhu A.Y., Zhou Y., Khan S., Deitsch K.W., Hao Q., Lin H. Plasmodium falciparum Sir2A preferentially hydrolyzes medium and long chain fatty acyl lysine. ACS Chem Biol 2011, 7:155-159.
56. Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y., He W., Yang K., et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics 2011, 10. M111.012658 1-12.
57. Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., Kim J., Woo J., Kim J.H., Choi B.H., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
58. He B., Du J., Lin H. Thiosuccinyl peptides as Sirt5-specific inhibitors. J Am Chem Soc 2012, 134:1922-1925.
59. Zhou Y., Zhang H., He B., Du J., Lin H., Cerione R.A., Hao Q. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5). J Biol Chem 2012, 287:28307-28314.